These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11103613)

  • 21. [Basic aspects of bone metabolic markers].
    Shiraki M; Chen JT; Kanda N; Hosoda K
    Nihon Rinsho; 1994 Sep; 52(9):2268-74. PubMed ID: 7967066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical markers of bone metabolism: application to understanding bone remodeling in children and adolescents.
    Levine MA
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():661-72. PubMed ID: 12795369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk.
    Weisman SM; Matkovic V
    Clin Ther; 2005 Mar; 27(3):299-308. PubMed ID: 15878383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biochemical markers of bone remodeling].
    Briot K; Roux C
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1009-13. PubMed ID: 16316769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers].
    Miura M
    Clin Calcium; 2009 Aug; 19(8):1160-9. PubMed ID: 19638700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical markers of bone turnover--clinical application and limitations].
    Kusec V
    Lijec Vjesn; 2005; 127(5-6):139-45. PubMed ID: 16281476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
    Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
    Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Early, noninvasive diagnostic of osteoporosis in men].
    Lepiarz-Rusek W; Kokocińska D
    Przegl Lek; 2005; 62(7):641-9. PubMed ID: 16463693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis.
    Majkić-Singh N; Ilić M; Ignjatović S; Aleksandra-Postić-Grujin
    Clin Lab; 2002; 48(7-8):407-13. PubMed ID: 12146575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of bone turnover in prostate cancer.
    Garnero P
    Cancer Treat Rev; 2001 Jun; 27(3):187-92; discussion 193-6. PubMed ID: 11417970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region, Poland.
    Filip RS; Zagórski J
    Ann Agric Environ Med; 2004; 11(2):255-9. PubMed ID: 15627333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
    Abildgaard N; Brixen K; Eriksen EF; Kristensen JE; Nielsen JL; Heickendorff L
    Haematologica; 2004 May; 89(5):567-77. PubMed ID: 15136220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
    Koizumi M; Takahashi S; Ogata E
    Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers.
    Ros I; Alvarez L; Guañabens N; Peris P; Monegal A; Vázquez I; Cerdá D; Ballesta AM; Muñoz-Gómez J
    J Bone Miner Metab; 2005; 23(3):266-9. PubMed ID: 15838631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
    Kruger MC; Booth CL; Coad J; Schollum LM; Kuhn-Sherlock B; Shearer MJ
    Nutrition; 2006; 22(11-12):1120-8. PubMed ID: 17030114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
    Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
    Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of serum CrossLaps as a predictor of changes in bone mineral density during estrogen replacement therapy; comparison with serum carboxyterminal telopeptide of type I collagen and urinary deoxypyridinoline.
    Okabe R; Inaba M; Nakatsuka K; Miki T; Naka H; Moriguchi A; Nishizawa Y
    J Bone Miner Metab; 2004; 22(2):127-31. PubMed ID: 14999523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers of bone health and osteoporosis risk.
    Eastell R; Hannon RA
    Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
    Noguchi M; Noda S
    J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.